NCT05946837 is a Phase 1 clinical trial of Indocyanine green (ICG) dye in Neck Pain, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT05946837?

NCT05946837 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT05946837?

Interventions in NCT05946837: Indocyanine green (ICG) dye, NIRF-LI imaging, Neuroglide pad.

What condition does NCT05946837 study?

NCT05946837 studies Neck Pain, Back Pain.

Is NCT05946837 still recruiting?

NCT05946837 is currently completed. Last updated 14 December 2023.

Last reviewed 2023-12-14 · How we verify

NCT05946837

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Near-infrared Fluorescence Lymphatic Imaging Assessment of Lymphatic Response to Pneumatic Back/Neck Lymphatic Drainage Delivered by a Pneumatic Manual Lymphatic Drainage Device

Completed Phase 1 Last updated 14 December 2023

What this trial tests

Phase 1 trial testing Indocyanine green (ICG) dye in Neck Pain in 4 participants. Completed in 1 September 2023.

Timeline

29 August 2023

Primary endpoint
1 September 2023

1 September 2023

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	4
Start date	29 August 2023
Primary completion	1 September 2023
Estimated completion	1 September 2023
Sites	1 location across United States

Drugs / interventions tested

Indocyanine green (ICG) dye — full drug profile →
NIRF-LI imaging
Neuroglide pad

Conditions studied

Neck Pain — all drugs for Neck Pain →
Back Pain — all drugs for Back Pain →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

18 and older, any sex, with Neck Pain or Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to objectively assess lymphatic function before, during, and immediately after Neuroglide treatment in lower trunk and leg lymphatic vessels, torso, axillary regions, inguinal regions, upper extremities, and cervical/neck and to determine any VAS (Visual Analog Scale, a commonly used measure of pain perception) score change after Neuroglide treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

NCT07163533 — Combined Effect of Kendall Exercises With Wearable Vibrotactile Feedback Sensor in Forward Head Posture · NA · recruiting
NCT07332845 — Symmetrical Scapula-pelvis Proprioceptive Neuromuscular Facilitation and Superficial Back Line in Chronic Neck Pain With · NA · recruiting
NCT07524075 — Effects of Muscle Energy Technique on Neck Disability and Cervical Range of Motion in Individuals With Non-Specific Neck · NA · recruiting
NCT07292350 — Investigation of the Effects of a Neuromuscular Control-Focused Posture Training Program in Butchers · NA · recruiting
NCT07290361 — Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT) · NA · recruiting

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05946837 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 14 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05946837.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing